Literature DB >> 24557028

Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.

Heather E Moss1, Weihua Gao2, Laura J Balcer3, Charlotte E Joslin4.   

Abstract

IMPORTANCE Retrospective studies have demonstrated disparate outcomes following acute optic neuritis in individuals of African descent compared with individuals of white race/ethnicity. However, published analyses of the prospectively collected Optic Neuritis Treatment Trial (ONTT) data identified no association between worse visual outcomes and black race/ethnicity. OBJECTIVES To investigate the associations of age, sex, and race/ethnicity with visual outcomes following acute optic neuritis through application of longitudinal data analysis techniques to the ONTT data set. DESIGN Secondary analysis of the ONTT (a prospective randomized controlled trial) data set. Our models included effects of treatment (placebo, oral prednisone, or intravenous methylprednisolone), time, and treatment × time interaction, as well as demographic covariates of age, sex, and race/ethnicity. SETTING AND PARTICIPANTS The ONTT data were collected at multiple centers in the United States. Patients of black (n = 58) and white (n = 388) race/ethnicity with acute optic neuritis who enrolled in the ONTT within 8 days of symptom onset were included in analyses. MAIN OUTCOMES AND MEASURES The contrast sensitivity and visual acuity (logMAR) in the affected eye were modeled using 2-stage mixed-effects regression techniques. All available follow-up data from baseline to 15 to 18 years were included. RESULTS The data identified no relationship of age, sex, or treatment with contrast sensitivity or visual acuity outcomes. Race/ethnicity was significantly related to contrast sensitivity (P < .001) and visual acuity (P < .001) during a 15-year period following acute optic neuritis, with black race/ethnicity being associated with worse scores for both. CONCLUSIONS AND RELEVANCE Race/ethnicity seems to be associated with contrast sensitivity and visual acuity outcomes in affected eyes following acute optic neuritis. To our knowledge, this is the largest cohort of black race/ethnicity with acute optic neuritis to be studied and represents the first evidence from a prospectively collected data set to support a hypothesis of race/ethnicity-dependent visual outcomes of acute optic neuritis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557028      PMCID: PMC4115276          DOI: 10.1001/jamaophthalmol.2013.7995

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  19 in total

1.  Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.

Authors:  Harold Merle; Stéphane Olindo; Séverine Jeannin; Ruddy Valentino; Hossein Mehdaoui; Florence Cabot; Angélique Donnio; Rabih Hage; Raymond Richer; Didier Smadja; Philippe Cabre
Journal:  Arch Ophthalmol       Date:  2012-07

2.  Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies.

Authors:  Hua Tang; Tom Quertermous; Beatriz Rodriguez; Sharon L R Kardia; Xiaofeng Zhu; Andrew Brown; James S Pankow; Michael A Province; Steven C Hunt; Eric Boerwinkle; Nicholas J Schork; Neil J Risch
Journal:  Am J Hum Genet       Date:  2004-12-29       Impact factor: 11.025

3.  The reliability of the Pelli-Robson contrast sensitivity chart.

Authors:  D B Elliott; K Sanderson; A Conkey
Journal:  Ophthalmic Physiol Opt       Date:  1990-01       Impact factor: 3.117

4.  Optic neuritis in African Americans.

Authors:  P H Phillips; N J Newman; M J Lynn
Journal:  Arch Neurol       Date:  1998-02

5.  Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1997-12

6.  Optic neuritis in an urban black African community.

Authors:  R Pokroy; G Modi; D Saffer
Journal:  Eye (Lond)       Date:  2001-08       Impact factor: 3.775

7.  The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.

Authors:  R W Beck; P A Cleary; J C Backlund
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

8.  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-12

9.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

10.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

View more
  13 in total

1.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

2.  Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Authors:  Bonnie Nga Kwan Choy; Alex Lap Ki Ng; Jimmy Shiu Ming Lai
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

3.  Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race.

Authors:  Tanyatuth Padungkiatsagul; John J Chen; Panitha Jindahra; Tetsuya Akaishi; Toshiyuki Takahashi; Ichiro Nakashima; Takayuki Takeshita; Heather E Moss
Journal:  Am J Ophthalmol       Date:  2020-07-15       Impact factor: 5.258

4.  Retinal damage and vision loss in African American multiple sclerosis patients.

Authors:  Dorlan J Kimbrough; Elias S Sotirchos; James A Wilson; Omar Al-Louzi; Amy Conger; Darrel Conger; Teresa C Frohman; Shiv Saidha; Ari J Green; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Journal:  Ann Neurol       Date:  2015-01-13       Impact factor: 10.422

Review 5.  Update on Optic Neuritis: An International View.

Authors:  Simon J Hickman; Axel Petzold
Journal:  Neuroophthalmology       Date:  2021-08-31

6.  Risk factors for idiopathic optic neuritis recurrence.

Authors:  Yi Du; Jing-Jing Li; Yu-Jiao Zhang; Kaijun Li; Jian-Feng He
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

7.  Clinical Features and Visual Outcomes of Optic Neuritis in Chinese Children.

Authors:  Huanfen Zhou; Wei Wang; Quangang Xu; Shaoying Tan; Shuo Zhao; Mo Yang; Chunxia Peng; Shihui Wei
Journal:  J Ophthalmol       Date:  2016-09-20       Impact factor: 1.909

Review 8.  The changing landscape of optic neuritis: a narrative review.

Authors:  Lindsey B De Lott; Jeffrey L Bennett; Fiona Costello
Journal:  J Neurol       Date:  2021-01-03       Impact factor: 4.849

9.  Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population.

Authors:  Chunxia Peng; Wei Wang; Quangang Xu; Shuo Zhao; Hongyang Li; Mo Yang; Shanshan Cao; Huanfen Zhou; Shihui Wei
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Optic Neuritis in the Older Chinese Population: A 5-Year Follow-Up Study.

Authors:  Junqing Wang; Huanfen Zhou; Limin Qin; Chunxia Peng; Jie Zhao; Da Teng; Dahe Lin; Nanping Ai; Quangang Xu; Shihui Wei
Journal:  J Ophthalmol       Date:  2017-12-11       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.